Quantum Computing Is Still Years Away. These 6 Stocks Show Who Is Closest to Real Revenue.

The article highlights a wide gap between quantum companies’ current revenues and the cash required to develop the technology: Q2 revenue was $80.1M for IonQ, $3.1M for D-Wave and $5.1M for Rigetti, while IBM funds a five-year, $10B quantum effort from its established cash flows. IonQ generated $144.7M in first-half 2026 revenue, but burned $254.8M in operating cash and its weighted average share count rose 47% year over year; D-Wave and Rigetti also rely on stock sales despite cash balances of $546.2M and roughly $541M, respectively. The analysis views IBM as best positioned to fund a long development period, while describing commercial quantum revenue as nascent and dilution as a key risk for the pure plays.

Analysis

The key market mechanism is financing duration, not qubit progress: when customer receipts do not fund development, equity prices and liquidity become part of the operating model. For QBTS and RGTI, strong order headlines can coexist with weak conversion; if pilots do not become recurring production workloads, ATM issuance can absorb much of the apparent upside for existing holders. IONQ has more commercial traction, but the sharp increase in cash use and share count makes revenue growth a poor proxy for per-share value creation. Its SkyWater deal adds integration and capital-allocation risk; verify the consideration, acquired capabilities, and post-close cash burn before treating it as a manufacturing advantage.

Over days, quantum news may move these high-beta names more than financing economics. Over 1–3 months, watch cash flow, ATM usage, and bookings-to-revenue conversion. Over 6–18 months, the thesis improves only if production deployments expand and funding needs decline. IBM is the durable funding vehicle, but quantum is not a clean way to express upside in a diversified company; NVDA’s enabling stack is also optionality, not yet a demonstrated material earnings driver. A relative-value stance—favoring balance-sheet durability over unfunded optionality—looks more robust than owning the sector basket. Falsifiers: sustained production revenue and improving operating cash burn at the pure plays, or evidence that IBM/NVDA quantum activity is becoming financially material. No valuation or borrow data are provided, so avoid sizing a naked short without checking both.

Key Decisions for Investors

• Prefer IBM over a broad basket of quantum pure plays for exposure to a long development cycle; treat this as a durability position, not a direct quantum-revenue trade. Reassess if IBM’s investment commitments begin to pressure consolidated cash generation or its stated commercialization timeline slips materially.
• Keep IONQ on a monitored, not automatically overweight, basis. Require evidence that revenue growth is translating into better cash efficiency and that share-count growth moderates; check post-SkyWater cash, deal economics, and acquired-asset contribution before adding.
• Avoid chasing QBTS or RGTI bookings alone. For a relative-value expression, consider a small, risk-limited long IBM / short QBTS-RGTI basket only after checking valuation, borrow availability, and event exposure; exit or reduce if production deployments convert bookings into sustained revenue and dilution slows.
• Treat NVDA and GOOG as indirect optionality rather than quantum earnings beneficiaries today. Revisit only on disclosed monetization, material customer revenue, or measurable contribution to guidance; adoption counts alone are not enough.